It is quite effective in human MS [21], failed in the C57BL6 mouse but strongly suppressed EAE in a human CD20 transgenic mouse on a C57BL6 genetic background [19] suggesting that high specificity for the human protein may preclude efficacy in the mouse unless the target is humanized. Here, MS4A1 is linked to myeloid sarcoma.